Selected research
Industry Growth & Trends
Global Fosfomycin Calcium Industry Growth and Trends Forecast to 2032
Market perspective
The global Fosfomycin Calcium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fosfomycin Calcium include Shanghai Xinya Pharmaceutical, Shanghai Wuzhou Pharmaceutical, Merck KGaA, Hubei Xunda Pharmaceutical, Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical, Shanxi Dongjin Pharmaceutical Co., Ltd., Shinpoong Pharm and Northeast Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Fosfomycin Calcium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Fosfomycin Calcium market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fosfomycin Calcium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fosfomycin Calcium.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Fosfomycin Calcium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Fosfomycin Calcium Market by Company
Shanghai Xinya Pharmaceutical
Shanghai Wuzhou Pharmaceutical
Merck KGaA
Hubei Xunda Pharmaceutical
Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical
Shanxi Dongjin Pharmaceutical Co., Ltd.
Shinpoong Pharm
Northeast Pharm
Manus Aktteva Biopharma LLP
FarmaSino Pharmaceutical
Ercros
Fosfomycin Calcium Segment by Type
Tablets
Injection
Fosfomycin Calcium Segment by Application
Medical
Microbiology
Others
Fosfomycin Calcium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Calcium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fosfomycin Calcium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Fosfomycin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injection
Applications
- Medical
- Microbiology
- Others
Companies covered
- Shanghai Xinya Pharmaceutical
- Shanghai Wuzhou Pharmaceutical
- Merck KGaA
- Hubei Xunda Pharmaceutical
- Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
- Guangxi Nanning Baihui Pharmaceutical
- Shanxi Dongjin Pharmaceutical Co., Ltd.
- Shinpoong Pharm
- Northeast Pharm
- Manus Aktteva Biopharma LLP
- FarmaSino Pharmaceutical
- Ercros
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Fosfomycin Calcium Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Fosfomycin Calcium Sales Estimates and Forecasts (2021-2032)
- 1.3 Fosfomycin Calcium Market by Type
- 1.3.1 Tablets
- 1.3.2 Injection
- 1.4 Global Fosfomycin Calcium Market Size by Type
- 1.4.1 Global Fosfomycin Calcium Market Size Overview by Type (2021-2032)
- 1.4.2 Global Fosfomycin Calcium Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Fosfomycin Calcium Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Fosfomycin Calcium Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Fosfomycin Calcium Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Fosfomycin Calcium Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Fosfomycin Calcium Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Fosfomycin Calcium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Fosfomycin Calcium Industry Trends
- 2.2 Fosfomycin Calcium Industry Drivers
- 2.3 Fosfomycin Calcium Industry Opportunities and Challenges
- 2.4 Fosfomycin Calcium Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Fosfomycin Calcium Revenue (2021-2026)
- 3.2 Global Top Players by Fosfomycin Calcium Sales (2021-2026)
- 3.3 Global Top Players by Fosfomycin Calcium Price (2021-2026)
- 3.4 Global Fosfomycin Calcium Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fosfomycin Calcium Major Company Production Sites & Headquarters
- 3.6 Global Fosfomycin Calcium Company, Product Type & Application
- 3.7 Global Fosfomycin Calcium Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fosfomycin Calcium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fosfomycin Calcium Players Market Share by Revenue in 2025
- 3.8.3 2025 Fosfomycin Calcium Tier 1, Tier 2, and Tier 3
4 Fosfomycin Calcium Regional Status and Outlook
- 4.1 Global Fosfomycin Calcium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Fosfomycin Calcium Historic Market Size by Region
- 4.2.1 Global Fosfomycin Calcium Sales in Volume by Region (2021-2026)
- 4.2.2 Global Fosfomycin Calcium Sales in Value by Region (2021-2026)
- 4.2.3 Global Fosfomycin Calcium Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Fosfomycin Calcium Forecasted Market Size by Region
- 4.3.1 Global Fosfomycin Calcium Sales in Volume by Region (2027-2032)
- 4.3.2 Global Fosfomycin Calcium Sales in Value by Region (2027-2032)
- 4.3.3 Global Fosfomycin Calcium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fosfomycin Calcium by Application
- 5.1 Fosfomycin Calcium Market by Application
- 5.1.1 Medical
- 5.1.2 Microbiology
- 5.1.3 Others
- 5.2 Global Fosfomycin Calcium Market Size by Application
- 5.2.1 Global Fosfomycin Calcium Market Size Overview by Application (2021-2032)
- 5.2.2 Global Fosfomycin Calcium Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Fosfomycin Calcium Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Fosfomycin Calcium Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Fosfomycin Calcium Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Fosfomycin Calcium Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Fosfomycin Calcium Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Fosfomycin Calcium Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Shanghai Xinya Pharmaceutical
- 6.1.1 Shanghai Xinya Pharmaceutical Company Information
- 6.1.2 Shanghai Xinya Pharmaceutical Business Overview
- 6.1.3 Shanghai Xinya Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Shanghai Xinya Pharmaceutical Fosfomycin Calcium Product Portfolio
- 6.1.5 Shanghai Xinya Pharmaceutical Recent Developments
- 6.2 Shanghai Wuzhou Pharmaceutical
- 6.2.1 Shanghai Wuzhou Pharmaceutical Company Information
- 6.2.2 Shanghai Wuzhou Pharmaceutical Business Overview
- 6.2.3 Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Product Portfolio
- 6.2.5 Shanghai Wuzhou Pharmaceutical Recent Developments
- 6.3 Merck KGaA
- 6.3.1 Merck KGaA Company Information
- 6.3.2 Merck KGaA Business Overview
- 6.3.3 Merck KGaA Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck KGaA Fosfomycin Calcium Product Portfolio
- 6.3.5 Merck KGaA Recent Developments
- 6.4 Hubei Xunda Pharmaceutical
- 6.4.1 Hubei Xunda Pharmaceutical Company Information
- 6.4.2 Hubei Xunda Pharmaceutical Business Overview
- 6.4.3 Hubei Xunda Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hubei Xunda Pharmaceutical Fosfomycin Calcium Product Portfolio
- 6.4.5 Hubei Xunda Pharmaceutical Recent Developments
- 6.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
- 6.5.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Company Information
- 6.5.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Business Overview
- 6.5.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio
- 6.5.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Recent Developments
- 6.6 Guangxi Nanning Baihui Pharmaceutical
- 6.6.1 Guangxi Nanning Baihui Pharmaceutical Company Information
- 6.6.2 Guangxi Nanning Baihui Pharmaceutical Business Overview
- 6.6.3 Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Product Portfolio
- 6.6.5 Guangxi Nanning Baihui Pharmaceutical Recent Developments
- 6.7 Shanxi Dongjin Pharmaceutical Co., Ltd.
- 6.7.1 Shanxi Dongjin Pharmaceutical Co., Ltd. Company Information
- 6.7.2 Shanxi Dongjin Pharmaceutical Co., Ltd. Business Overview
- 6.7.3 Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio
- 6.7.5 Shanxi Dongjin Pharmaceutical Co., Ltd. Recent Developments
- 6.8 Shinpoong Pharm
- 6.8.1 Shinpoong Pharm Company Information
- 6.8.2 Shinpoong Pharm Business Overview
- 6.8.3 Shinpoong Pharm Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Shinpoong Pharm Fosfomycin Calcium Product Portfolio
- 6.8.5 Shinpoong Pharm Recent Developments
- 6.9 Northeast Pharm
- 6.9.1 Northeast Pharm Company Information
- 6.9.2 Northeast Pharm Business Overview
- 6.9.3 Northeast Pharm Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Northeast Pharm Fosfomycin Calcium Product Portfolio
- 6.9.5 Northeast Pharm Recent Developments
- 6.10 Manus Aktteva Biopharma LLP
- 6.10.1 Manus Aktteva Biopharma LLP Company Information
- 6.10.2 Manus Aktteva Biopharma LLP Business Overview
- 6.10.3 Manus Aktteva Biopharma LLP Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Manus Aktteva Biopharma LLP Fosfomycin Calcium Product Portfolio
- 6.10.5 Manus Aktteva Biopharma LLP Recent Developments
- 6.11 FarmaSino Pharmaceutical
- 6.11.1 FarmaSino Pharmaceutical Company Information
- 6.11.2 FarmaSino Pharmaceutical Business Overview
- 6.11.3 FarmaSino Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 FarmaSino Pharmaceutical Fosfomycin Calcium Product Portfolio
- 6.11.5 FarmaSino Pharmaceutical Recent Developments
- 6.12 Ercros
- 6.12.1 Ercros Company Information
- 6.12.2 Ercros Business Overview
- 6.12.3 Ercros Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Ercros Fosfomycin Calcium Product Portfolio
- 6.12.5 Ercros Recent Developments
7 North America by Country
- 7.1 North America Fosfomycin Calcium Sales by Country
- 7.1.1 North America Fosfomycin Calcium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Fosfomycin Calcium Sales by Country (2021-2026)
- 7.1.3 North America Fosfomycin Calcium Sales Forecast by Country (2027-2032)
- 7.2 North America Fosfomycin Calcium Market Size by Country
- 7.2.1 North America Fosfomycin Calcium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Fosfomycin Calcium Market Size by Country (2021-2026)
- 7.2.3 North America Fosfomycin Calcium Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Fosfomycin Calcium Sales by Country
- 8.1.1 Europe Fosfomycin Calcium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Fosfomycin Calcium Sales by Country (2021-2026)
- 8.1.3 Europe Fosfomycin Calcium Sales Forecast by Country (2027-2032)
- 8.2 Europe Fosfomycin Calcium Market Size by Country
- 8.2.1 Europe Fosfomycin Calcium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Fosfomycin Calcium Market Size by Country (2021-2026)
- 8.2.3 Europe Fosfomycin Calcium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Fosfomycin Calcium Sales by Country
- 9.1.1 Asia-Pacific Fosfomycin Calcium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Fosfomycin Calcium Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Fosfomycin Calcium Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Fosfomycin Calcium Market Size by Country
- 9.2.1 Asia-Pacific Fosfomycin Calcium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Fosfomycin Calcium Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Fosfomycin Calcium Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Fosfomycin Calcium Sales by Country
- 10.1.1 South America Fosfomycin Calcium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Fosfomycin Calcium Sales by Country (2021-2026)
- 10.1.3 South America Fosfomycin Calcium Sales Forecast by Country (2027-2032)
- 10.2 South America Fosfomycin Calcium Market Size by Country
- 10.2.1 South America Fosfomycin Calcium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Fosfomycin Calcium Market Size by Country (2021-2026)
- 10.2.3 South America Fosfomycin Calcium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Fosfomycin Calcium Sales by Country
- 11.1.1 Middle East and Africa Fosfomycin Calcium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Fosfomycin Calcium Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Fosfomycin Calcium Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Fosfomycin Calcium Market Size by Country
- 11.2.1 Middle East and Africa Fosfomycin Calcium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Fosfomycin Calcium Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Fosfomycin Calcium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Fosfomycin Calcium Value Chain Analysis
- 12.1.1 Fosfomycin Calcium Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Fosfomycin Calcium Production Mode & Process
- 12.2 Fosfomycin Calcium Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Fosfomycin Calcium Distributors
- 12.2.3 Fosfomycin Calcium Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst